Concepedia

Alexandria A. Oviatt

AA

5

Publications

116

Citations

5

H-Index

2018

Active since

Affiliations

Vanderbilt University(Current)

GlaxoSmithKline (United States)

VA Tennessee Valley Healthcare System

National Institutes of Health

National Heart Lung and Blood Institute

Alexandria A. Oviatt is an author at Vanderbilt University specializing in pharmacology, molecular pharmacology, and medicine.

ORCID

Top concepts

Publications per year

2018–2024

5

Publications

5

Interactions between Gepotidacin and <i>Escherichia coli</i> Gyrase and Topoisomerase IV: Genetic and Biochemical Evidence for Well-Balanced Dual-Targeting

Alexandria A. Oviatt, Elizabeth G. Gibson, Jianzhong Huang et al. · ACS Infectious Diseases · 2024 · 33 citations · Full text

Target-Mediated Fluoroquinolone Resistance in <i>Neisseria gonorrhoeae</i>: Actions of Ciprofloxacin against Gyrase and Topoisomerase IV

Jessica A. Collins, Alexandria A. Oviatt, Pan F. Chan et al. · ACS Infectious Diseases · 2024 · 30 citations · Full text

Bimodal Actions of a Naphthyridone/Aminopiperidine-Based Antibacterial That Targets Gyrase and Topoisomerase IV

Elizabeth G. Gibson, Alexandria A. Oviatt, Mónica Cacho et al. · Biochemistry · 2019 · 19 citations · Full text

Two-Dimensional Gel Electrophoresis to Resolve DNA Topoisomers

Elizabeth G. Gibson, Alexandria A. Oviatt, Neil Osheroff · Methods in molecular biology · 2020 · 18 citations · Full text

, , +5

Polyamine-containing etoposide derivatives as poisons of human type II topoisomerases: Differential effects on topoisomerase IIα and IIβ

Alexandria A. Oviatt, A. K. Jissy, Elirosa Minniti et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 16 citations · Full text

, , +6

Rows per page

1–5 of 5